文献速递血管炎自身炎症与 IgG4 相关病

VEXAS综合征:意大利单中心血管炎队列病例系列

VEXAS Syndrome: A Case Series From a Single-Center Cohort of Italian Patients With Vasculitis.
PubMed 文献 · Arthritis Rheumatol · 2022-03-03

该研究采用临床表型优先策略,回顾性分析2013年至今单中心147例连续男性血管炎患者,识别出7例伴VEXAS特征的血管炎患者,其中5例接受UBA-1测序,3例确诊VEXAS综合征,且3例均符合WHO骨髓增生异常综合征诊断标准。这是首报VEXAS综合征与ANCA相关性血管炎相关。

要点

  • 血管炎患者若治疗抵抗、炎症标志物持续升高伴血液学异常,应怀疑VEXAS综合征。
  • 骨髓涂片发现空泡及UBA-1测序可辅助确诊VEXAS综合征。
  • 该研究首次报告VEXAS综合征与ANCA相关性血管炎相关。

核心结论

  • 在意大利单中心血管炎队列中识别出VEXAS综合征患者,并首次报告其与ANCA相关性血管炎相关。
  • 数据强调在评估各类系统性血管炎患者时需考虑VEXAS综合征。

研究设计与样本

  • 回顾性单中心队列研究,纳入2013年至今连续147例男性血管炎患者。
  • 采用临床表型优先策略,筛选治疗抵抗、炎症标志物持续升高及血液学异常者。
  • 对骨髓穿刺液检查空泡,并用外周血白细胞或骨髓组织基因组DNA行UBA-1测序。

主要发现

  • 共识别7例血管炎伴VEXAS综合征特征的患者。
  • 5例接受UBA-1测序的患者中3例确诊VEXAS综合征,其中1例为死后诊断。
  • 3例确诊患者骨髓穿刺均见VEXAS综合征特征性空泡,且均符合WHO骨髓增生异常综合征确诊标准。
  • 3例确诊患者细胞遗传学分析均显示正常核型。

关键数值与推荐

  • VEXAS综合征诊断依据:骨髓空泡、UBA-1测序结果及临床特征。
  • 3例确诊患者均满足WHO骨髓增生异常综合征确诊标准。
  • 3例确诊患者核型分析均为正常核型。

临床怎么用

  • 对男性血管炎患者,若出现治疗抵抗、炎症标志物持续升高及血液学异常,应警惕VEXAS综合征。
  • 可考虑行骨髓穿刺检查空泡及UBA-1测序以辅助诊断。
  • 在ANCA相关性血管炎评估中应将VEXAS综合征纳入鉴别诊断。

局限性

  • 单中心回顾性研究,样本量有限。
  • 部分患者未行UBA-1测序,1例为死后诊断。
  • VEXAS综合征与ANCA相关性血管炎的关联需进一步研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To identify patients with VEXAS syndrome (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic syndrome) from a single-center cohort of Italian patients with vasculitis, using a clinically oriented phenotype-first approach. METHODS: We retrospectively reviewed the clinical records of 147 consecutive male patients followed up in our vasculitis clinic from 2013 to date. All patients with a diagnosis of vasculitis and treatment-resistant manifestations of inflammation, persistently elevated inflammation markers, and hematologic abnormalities were identified. Bone marrow aspirates were examined for the presence of vacuoles. Sequencing of ubiquitin-activating enzyme E1 (UBA-1) was performed using genomic DNA from peripheral blood leukocytes or bone marrow tissue. RESULTS: Seven patients with vasculitis and concomitant features of VEXAS syndrome were identified. A final diagnosis of VEXAS syndrome was made in 3 of the 5 patients who underwent sequencing of UBA-1 (diagnosis was made postmortem for 1 patient). In all 3 patients, examination of the bone marrow aspirate revealed vacuoles characteristic of VEXAS syndrome, and all 3 patients met the definitive World Health Organization criteria for myelodysplastic syndrome. Cytogenetic analysis showed normal karyotypes in all 3 patients. CONCLUSION: To our knowledge, this is the first report of VEXAS syndrome associated with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis. Our data emphasize the need to consider VEXAS syndrome when evaluating patients with various forms of systemic vasculitis. The novel association between VEXAS syndrome and ANCA-associated vasculitis reported herein warrants further investigation.

来源:Arthritis Rheumatol,查看原文。版权归原作者所有。

引用

  1. Muratore F, Marvisi C, Castrignanò P, et al. VEXAS Syndrome: A Case Series From a Single-Center Cohort of Italian Patients With Vasculitis. Arthritis Rheumatol. 2022. PMID: 34611997. doi:10.1002/art.41992

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。